Compare Agilent Technologies Inc (A) vs GXO Logistics Inc (GXO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs GXO Logistics Inc — how do they compare? Agilent Technologies Inc trades at $147.6 (market cap $42.22B), while GXO Logistics Inc trades at $47.74 (market cap $5.37B). The key difference: Agilent Technologies Inc is far larger — about 7.9× GXO Logistics Inc's market cap, and Agilent Technologies Inc pays a 0.68% dividend while GXO Logistics Inc pays none. Which is the better fit depends on your goals.
| A | GXO | |
|---|---|---|
Market Cap | $42.22B | $5.37B |
Sector | Health | Industrials |
52-Week High | $157.20 | $65.59 |
52-Week Low | $110.24 | $45.52 |
Enterprise Value | $43.77B | $10.72B |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.
GXO trades at $47.64, up 1.45% today, with a bearish technical signal despite recent earnings beats. The stock shows strong analyst support with an 88.9% buy rating and a $65.67 consensus price target, implying significant upside. Recent news highlights growth in data center logistics and new partnerships, though margins remain a challenge. Cash flow improved in 2026, with net cash flow reaching $566 million.
The outlook is mixed; strong revenue growth and analyst optimism contrast with margin pressures and a bearish technical trend. Key risks include cost absorption issues and competitive threats, but the high price target suggests Wall Street sees long-term value. Investors should weigh solid fundamentals against near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →
